Bermingham Nessan Insider Trades

Insider Trading History

Track insider trading activity for Bermingham Nessan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Korro Bio
Korro Bio KRRO
Director
Holding Value $67.2k 6,010 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$89.4k 6,010 shares
$14.87
$11.18
Korro Bio
Korro Bio KRRO
Director
Holding Value $58k 5,190 shares
Last Trade
Jun 11, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$219k 5,190 shares
$42.19
$11.18
Frequency Therapeutics
Frequency Therapeutics FREQ
Director
Holding Value $20.1k 67,061 shares
Last Trade
Nov 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$27.5k 91,773 shares
$0.30
$0.30
Korro Bio
Korro Bio KRRO
Director
Holding Value $276k 24,712 shares
Last Trade
Nov 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$27.5k 91,773 shares
$0.30
$11.18
F-star Therapeutics
F-star Therapeutics FSTX
Director
Holding Value $45.1k 6,328 shares
Last Trade
Mar 08, 2023 Sale (Tender)Reported as Tender on SEC Form 4.
$695k 97,547 shares
$7.12
$7.12
F-star Therapeutics
F-star Therapeutics FSTX
Director
Holding Value $0 0 shares
Last Trade
Mar 08, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$573k 80,439 shares
$7.12
$7.12
F-star Therapeutics
F-star Therapeutics FSTX
Director
Holding Value $142k 20,000 shares
Last Trade
Jun 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$136k 40,000 shares
$3.41
$7.12
F-star Therapeutics
F-star Therapeutics FSTX
Director
Holding Value $142k 20,000 shares
Last Trade
Jun 04, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$138k 20,000 shares
$6.88
$7.12
F-star Therapeutics
F-star Therapeutics FSTX
Director
Holding Value $740k 103,875 shares
Last Trade
Feb 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$746k 87,000 shares
$8.57
$7.12
F-star Therapeutics
F-star Therapeutics FSTX
Director
Holding Value $243k 34,111 shares
Last Trade
Nov 20, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$61.7k 50,986 shares
$1.21
$7.12
F-star Therapeutics
F-star Therapeutics FSTX
Director
Holding Value $120k 16,875 shares
Last Trade
Nov 20, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.4k 16,875 shares
$1.21
$7.12
Intellia Therapeutics
Intellia Therapeutics NTLA
President & CEO
Holding Value $4.31M 292,500 shares
Last Trade
Dec 12, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.35M 292,500 shares
$18.30
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
President & CEO
Holding Value $6.76M 458,250 shares
Last Trade
Dec 08, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.92M 188,286 shares
$20.82
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
President & CEO
Holding Value $8.55M 579,959 shares
Last Trade
Dec 07, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.54M 262,280 shares
$21.14
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
President & CEO
Holding Value $10.3M 696,000 shares
Last Trade
Dec 06, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.54M 223,000 shares
$20.34
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
President & CEO
Holding Value $11.7M 795,033 shares
Last Trade
Jun 01, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$100k 8,400 shares
$11.95
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
President & CEO
Holding Value $3.98M 270,000 shares
Last Trade
Jan 06, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.75M 270,000 shares
$13.88
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
President & CEO
Holding Value $11.6M 786,633 shares
Last Trade
May 11, 2016 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$11M 437,019 shares
$25.25
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
President & CEO
Holding Value $0 0 shares
Last Trade
May 11, 2016 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$17.1M 675,883 shares
$25.25
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
10% owner, President & CEO
Holding Value $5.16M 349,614 shares
Last Trade
May 05, 2016 Sale
No data
No data
$14.75

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up